Company intelligence / Profile preview
Rewind Therapeutics
Leuven, Flemish Region, Belgiumrwdtx.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Preclinical
01
Overview
Rewind Therapeutics develops first-in-class therapies aimed at restoring the myelin sheath lost in debilitating diseases such as multiple sclerosis and optic neuritis. Their approach focuses on promoting remyelination by enabling proper function and expansion of oligodendrocyte lineage cells, potentially halting or reversing disease progression. The company has a strong patent estate supporting its novel therapeutic approach.
- Therapeutic areas
- Neurology
- Modalities
- Small molecules (implied by therapeutic development focus)Cell biology-based therapeutics targeting remyelination processes
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Investors including Boehringer Ingelheim Venture Fund, M-Ventures, PMV (Participatiemaatschappij Vlaanderen), Gemma Frisius Fonds, CD3/KU Leuven technology transfer office, Sunstone Life Science Ventures
Beyond the preview
Go deeper on Rewind Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rewind Therapeutics.